• KOL
    • Breast Cancer
    • Gilbert H Fletcher
    • Gilbert H Fletcher: Influence Statistics

      Gilbert H Fletcher

      Gilbert H Fletcher

      Department of Radiotherapy, M.D. Anderson, Cancer Center, 1515 Holocombe Boulevard, 77030, Houston, TX, USA | Department of Radiotherapy, M.D. Anderson Cancer Center, 1515 ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Gilbert H Fletcher:Expert Impact

      Concepts for whichGilbert H Fletcherhas direct influence:Breast cancer,Uterine cervix,Squamous cell,Squamous cell carcinoma,Radiation therapy,Intracavitary radium,Elective irradiation,Postoperative irradiation.

      Gilbert H Fletcher:KOL impact

      Concepts related to the work of other authors for whichfor which Gilbert H Fletcher has influence:Radiation therapy,Squamous cell,Breast cancer,Local control,Uterine cervix,Distant metastases,Nasopharyngeal carcinoma.

      KOL Resume for Gilbert H Fletcher

      Year
      1993

      Department of Radiotherapy, M.D. Anderson, Cancer Center, 1515 Holocombe Boulevard, 77030, Houston, TX, USA

      1991

      The University of Texas. M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030 USA

      1990

      The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, U.S.A.

      M. D. Anderson Cancer Center, USA

      1989

      The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA

      1988

      The University of Texas M.D. Anderson Hospital and Tumor Hospital, 77030, Houston, TX, USA

      Division of Radiotherapy, University of Texas M.D. Anderson Cancer Center, Houston, 77030.

      1987

      Division of Radiotherapy, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston Houston, Texas 77030,USA

      1986

      Department of Clinical Radiotherapy, The University of Texas, M. D. Anderson Hospital and Tumor Institute at Houston, Houston, TX, USA

      1985

      Department of Radiotherapy, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Texas Medical Center, Houston, Texas

      1984

      Department of Radiotherapy, The University of Texas, M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas 77030, USA

      1983

      Department of Radiotherapy, The University of Texas System Cancer Center M. D. Anderson Hospital and Tumor Institute, Houston, TX 77030, USA

      Division of Radiotherapy, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, 6723 Bertner Avenue, Houston, TX 77030, U.S.A.

      1982

      Department of Radiotherapy, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute of, Houston, TX 77030, USA

      Senior Radiotherapist, Prince of Wales Hospital, Randwick, N.S.W. 2031 Australia

      Division of Radiotherapy, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas

      1981

      Department of Radiotherapy, The University of Texas System Cancer Center M.D. Anderson Hospital and Tumor Institute, Houston TX 77030, USA

      1980

      M. D. Anderson Hospital and Tumor Institute, Houston, Texas

      1979

      Department of Radiotherapy

      The University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston, TX 77030, U.S.A.

      1978

      Department of Radiotherapy, M. D. Anderson Hospital and Tumor Institute, The University of Texas System Cancer Center, Houston, TX 77030, U.S.A.

      1977

      Department of Radiotherapy, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX 77030

      1976

      Department of Radiotherapy, the University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston, Texas

      1975

      Houston, Tex.

      1974

      Department of Radiotherapy, The University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston, TX 77025

      1973

      University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Department of Gynecology, Houston, Texas, USA

      1972

      Radiotherapy Department, M. D. Anderson Hospital and Tumor Institute, Houston, Tex. 77025

      Department of Gynecology, M. D. Anderson Hospital and Tumor Institute Houston, Texas, USA

      1971

      University of Texas, M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Tex

      1970

      From the M.D. Anderson Hospital, Houston, Texas, USA

      Department of Radiotherapy and Department of Surgery, Section of Gynecology, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston, Texas

      1968

      Department of Radiotherapy, University of Texas, MD Anderson Hospital and Tumor Hospital, Houston, Texas, USA

      1967

      Department of Radiotherapy, The University of Texas M. D. Anderson Hospital and Tumor Institute, Houston, Texas, USA

      1964

      University of Texas M. D. Anderson Hospital and Tumor Institute, Houston

      1963

      Section of Radiotherapy and the departments of Medicine and Surgery, Head and Neck Service of The University of Texas M. D. Anderson Hospital and Tumor Institute, Texas Medical Center, 6723 Bertner St., Houston 25, Texas

      1962

      From the Departments of Surgery and Radiology, The University of Texas M. D. Anderson Hospital and Tumor Institute, Houston, Texas

      1959

      University of Texas M. D. Anderson Hospital and Tumor Institute Houston, Texas, USA

      1958

      University of Texas M. D. Anderson Hospital and Tumor Institute Houston, Texas USA

      Sign-in to see all concepts, it's free!
      Sample of concepts for which Gilbert H Fletcher is among the top experts in the world.
      Concept World rank
      local tenor control #1
      order late morbidity #1
      survival dsrfs #1
      oral cavity charts #1
      gross cancer patients #1
      characteristics irradiation sources #1
      guidelines radiotherapeutic techniques #1
      cre formulae #1
      irradiation chest #1
      oropharynx irradiation #1
      complication rate dose #1
      radiologic uterine neoplasms #1
      publication female technology #1
      supervoltage roentgentherapy #1
      treatment intracavitary #1
      breast cancer curable #1
      adenocarcinoma uterus1 #1
      radiation therapy points #1
      successful combination surgery #1
      original preloadable model #1
      occult deposits #1
      peripheral lymphatic failures #1
      postoperative irradiation #1
      terms therapeutic effectiveness #1
      dome colpostats addition #1
      diagnosis situ carcinoma #1
      cervix simple hysterectomy #1
      2000 rad fractions #1
      lateral fornices #1
      supervoltage #1
      management neck disease #1
      blumenson hypotheses #1
      extended field technique #1
      dsrfs rate #1
      large massive tumors #1
      neck metastases recurrences #1
      uterine cervix minimum #1
      supervoltage radiotherapy #1
      combined treatment management #1
      local vocal cords #1
      radiotherapy treatment schemes #1
      small radiotherapy radiotherapy #1
      Sign-in to see all concepts, it's free!

      Prominent publications by Gilbert H Fletcher

      KOL-Index: 11295

      1.1. The records of 596 patients with previously untreated squamous cell carcinoma of the tonsillar fossa, base of the tongue, supraglottic larynx, and hypopharynx were reviewed to evaluate the efficacy of three modalities of initial treatment of cervical lymph nodes.2.2. Elective irradiation of the neck is indicated in patients with tumors of the tonsillar fossa and base of the tongue. For patients with lesions of the supraglottic larynx and hypopharynx and a clinically negative neck, ...

      Known for Supraglottic Larynx | Cervical Lymph | Cell Carcinoma | Node Metastases | Neck Patients
      KOL-Index: 11148

      This is a retrospective study of 61 patients with clinically diagnosed breast cancer (IBC) treated with multimodality therapy between September 1977 and September 1985. All patients were scheduled to receive three courses of doxorubicin-based chemotherapy followed by mastectomy, further chemotherapy, and postoperative irradiation. Ten patients (16%) obtained a complete response, defined as either resolution of the clinical signs of inflammatory breast cancer (IBC) (4 patients) or no ...

      Known for Inflammatory Breast Cancer | Complete Response | Mastectomy Chemotherapy | Chest Wall | Local Control Patients
      KOL-Index: 10745

      Clinical and experimental evidence for divergent changes in early and late radiation responses in normal tissues after changes in dose fractionation indicate a greater sensitivity of late responses to changes in dose per fraction. In experimental studies of the effect of dose per fraction on early and late isoeffects, a larger number-of-fractions exponent for the late responses is the rule. These findings imply that the shape of the dose-survival curve for the target cells whose ...

      Known for Dose Fraction | Target Cells | Late Radiation | Normal Tissues | Acute Effects
      KOL-Index: 10091

      The charts of 431 patients with squamous cell carcinoma of the supraglottic larynx observed at the M.D. Anderson Hospital between January, 1954, and June, 1971, were analyzed. This study is concerned with those patients who had a technically resectable lesion. Emphasis is directed to the analysis of the effectiveness of primary irradiation instead of partial laryngectomy for those lesions which are technically suitable for a partial resection and to define the groups of patients which ...

      Known for Supraglottic Larynx | Patients Surgery | Postoperative Irradiation | Squamous Cell | Partial Laryngectomy
      KOL-Index: 9677

      This is an analysis of 304 patients with invasive, previously untreated T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy at the University of Florida between October 1964 and December 1984. All patients had a minimum 2-year follow-up and 82% had at least 5 years of follow-up. Patients were excluded from the analysis of local control if they died within 2 years of treatment with the primary site continuously disease-free; all patients were included in the ...

      Known for Glottic Larynx | Local Control | Squamous Cell | Radiation Therapy | 2 Years
      KOL-Index: 9363

      Treatment with several doses per day offers the prospect of a significant therapeutic gain using readily available low LET beams. These regimens can be classified as either accelerated fractionation or hyperfractionation according to their rationales. With accelerated fractionation a conventional number of dose fractions is delivered in a significantly shortened overall treatment time in order to reduce the opportunity for tumor cell regeneration during treatment. With ...

      Known for Accelerated Fractionation | Dose Fractions | Radiation Humans | Day Treatment | Potential Doubling
      KOL-Index: 9060

      The charts of 5,019 previously untreated patients with squamous cell carcinoma of the upper respiratory and digestive tracts who completed treatment for cure from January 1948 through August 1973, were reviewed. These patients had no evidence of distant metastases when initially evaluated. Five hundred and forty-six patients developed clinical evidence of distant metastases. The overall incidence of distant metastases was 10.9%, varying from 3.1% for vocal cord cancers to 28.1% for ...

      Known for Distant Metastases | Squamous Cell Carcinoma | Neck Neoplasms Humans | Common Sites | Neoplasm Metastasis
      KOL-Index: 8973

      Between July 1968 and December 1983, 150 patients with previously untreated squamous cell carcinomas of the tonsillar fossa received megavoltage external beam irradiation with curative intent at U.T.M.D. Anderson Cancer Center. These patients were treated following a series of patients who had received radiotherapy between 1954 and May 1968. One hundred and thirty-seven patients were treated with conventional fractionation, the mean doses to the primary being 64.3 Gy, 67.8 Gy, 70.2 Gy, ...

      Known for Tonsillar Fossa | Squamous Cell | Definitive Radiotherapy | Patients T4 Disease | T4 Lesions
      KOL-Index: 8633

      Between January 1967 and December 1974, 254 patients with carcinoma of the uterine cervix were treated with either intracavitary radium and parametrial irradiation or 2000 rad whole pelvis irradiation followed by intracavitary radium and parametrial irradiation. In general, these patients had tumors of relatively limited volume and vaginal and uterine anatomy that was favorable for intracavitary radium. Not all patients had a lymphangiogram performed prior to irradiation. Of those who ...

      Known for Intracavitary Radium | Uterine Cervix | Severe Complications | Irradiation Patients | Retrospective Studies
      KOL-Index: 8581

      The evolution of neck disease in 180 patients with controlled squamous cell carcinomas of the oral tongue, floor of the mouth, and faucial arch having initially clinically positive nodes neither fixed nor bilateral has been analyzed by modality of treatment of the neck disease, i.e., radical neck dissection, combined radical neck dissection and irradiation, and irradiation. There is a shift to earlier primary lesions and less extensive neck disease in the patients having had a radical ...

      Known for Oral Tongue | Neck Disease | Squamous Cell | Floor Mouth | Combined Treatment
      KOL-Index: 8214

      One hundred and two patients with squamous cell carcinoma of the oral cavity or oropharynx were treated from January 1955 through August 1976 with surgical excision followed by irradiation. Twelve patients had T2 lesions and 90 had T3 or T4 lesions. Failures above the clavicles were associated with disease present at the margins of resection, location of the recurrence close to the periphery, or outside of the irradiated portals. Failure in the neck essentially were a result of no ...

      Known for Oral Cavity | Squamous Cell | Postoperative Irradiation | Neck Neoplasms Humans | Control Rate
      KOL-Index: 7720

      Between 1955 and 1984, 376 patients with locoregionally advanced breast carcinoma were treated at The University of Texas M. D. Anderson Cancer Center with mastectomy and irradiation and without adjuvant chemotherapy. Patients with inflammatory carcinoma or synchronous bilateral primary tumors were excluded. There were 202 patients with Stage IIIA disease and 174 patients with Stage IIIB disease (AJC Staging--1983). In 124 patients the surgical management was confined to the breast ...

      Known for Radical Mastectomy | Advanced Carcinoma | Stage Iiib Disease | Adjuvant Chemotherapy | Follow Studies
      KOL-Index: 7688

      A retrospective study of 702 patients with clinically positive nodes associated with squamous cell carcinoma of the oral cavity, supraglottic larynx, and hypopharynx observed from 1954 to 1968 was done. The policies of treatment for the neck were not standardized during those years. Three hundred eleven patients who survived 24 months with the primary lesion controlled were divided into two groups: 1) those whose neck was treated by surgery alone; and 2) those who had combined radiation ...

      Known for Squamous Cell Carcinoma | Neck Neoplasms | Combined Treatment | Oral Cavity | Elective Irradiation
      KOL-Index: 7427

      This study is a retrospective analysis of the results of definitive treatment with irradiation alone or in combination with surgery for patients with squamous cell carcinoma of the pharyngeal walls. For the 164 patients who were treated with irradiation alone, the failure rate ranged from 9% for T1 lesions to 63% for T4 lesions. Surgical salvage was successful in 11 of the 66 patients in whom radiotherapy failed at the primary site. Fatal complications developed in 5% of the patients, ...

      Known for Pharyngeal Walls | Squamous Cell | Radiotherapy Patients | Irradiation Treatment | Tumor Dose

      Key People For Breast Cancer

      Top KOLs in the world
      #1
      Ahmedin M Jemal
      united states breast cancer addis ababa
      #2
      Gabriel N Hortobagyi
      breast cancer neoadjuvant chemotherapy estrogen receptors
      #3
      Rebecca L Siegel
      united states colorectal cancer incidence rates
      #4
      Charles M Perou
      breast cancer gene expression intrinsic subtypes
      #5
      Freddie Ian Bray
      cancer incidence nordic countries mortality rates
      #6
      Jacques Ferlay
      cancer incidence global burden latin america

      Department of Radiotherapy, M.D. Anderson, Cancer Center, 1515 Holocombe Boulevard, 77030, Houston, TX, USA | Department of Radiotherapy, M.D. Anderson Cancer Center, 1515 Holocombe Boulevard, 77030, Houston, TX, USA | Department of Radiotherapy, Div

    Download on the App StoreGet it on Google Play

    Copyright © 2023 KOL - Key Opinion Leaders, LLC.

    KOL does not provide medical advice, diagnosis or treatment.